This review outlines the evidence on how AI and machine learning can address unmet needs in autoimmune liver diseases. In PSC, MRCP+ metrics can significantly improve the current diagnostic approach and risk prediction. In AIH, LiverMultiScan’s cT1 is described as an accurate non-invasive biomarker for risk stratification and monitoring, enabling precision-medicine workflows.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?